Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties.

[1]  Mengsu Yang,et al.  Trichosanthin's interfacial interactions with phospholipids: a monolayer study. , 2004, Colloids and surfaces. B, Biointerfaces.

[2]  F. Stirpe.  Ribosome-inactivating proteins. , 2004, Toxicon : official journal of the International Society on Toxinology.

[3]  D. Ouyang,et al.  Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro. , 2004, Biochemical and biophysical research communications.

[4]  P. Shaw,et al.  Change in pH-dependent Membrane Insertion Characteristics of Trichosanthin Caused by Deletion of Its Last Seven C-terminal Amino Acid Residues , 2003, Biochemistry (Moscow).

[5]  P. Shaw,et al.  Trichosanthin Induces Leakage and Membrane Fusion of Liposome , 2003, IUBMB life.

[6]  P. Shaw,et al.  Substrate binding and catalysis in trichosanthin occur in different sites as revealed by the complex structures of several E85 mutants. , 2003, Protein engineering.

[7]  P. Shaw,et al.  The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability. , 2003, Protein engineering.

[8]  W. Chan,et al.  Receptor-mediated endocytosis of trichosanthin in choriocarcinoma cells. , 2003, Toxicology.

[9]  Roger L. Williams,et al.  Structural basis for the interaction of [E160A-E189A]-trichosanthin with adenine. , 2003, Toxicon : official journal of the International Society on Toxinology.

[10]  Yong-tang Zheng,et al.  Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin. , 2003, Biochemical and biophysical research communications.

[11]  Yong-tang Zheng,et al.  Anti‐HIV‐1 property of trichosanthin correlates with its ribosome inactivating activity , 2002, FEBS letters.

[12]  J. Yu,et al.  Identification of the amino acid residues in trichosanthin crucial for IgE response. , 2002, Biochemical and biophysical research communications.

[13]  Y. Gong,et al.  Capillary electrophoresis and circular dichroism study of trichosanthin and its mutants. , 2002, Talanta.

[14]  S. Sui,et al.  Effect of phospholipid on trichosanthin adsorption at the air-water interface. , 2001, Biochimica et biophysica acta.

[15]  S. Sui,et al.  The interaction of trichosanthin with supported phospholipid membranes studied by surface plasmon resonance. , 2001, Biochimica et biophysica acta.

[16]  Y. Gong,et al.  Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. , 2001, The Biochemical journal.

[17]  P. Shaw,et al.  Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B. , 2001, European journal of biochemistry.

[18]  S. Sui,et al.  The membrane insertion of trichosanthin is membrane-surface-pH dependent. , 2000, The Biochemical journal.

[19]  T. Ng,et al.  The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV‐1 integrase , 2000, FEBS letters.

[20]  P. Shaw,et al.  Trichosanthin interacts with and enters cells via LDL receptor family members. , 2000, Biochemical and biophysical research communications.

[21]  P. Shaw,et al.  Engineering of a mini-trichosanthin that has lower antigenicity by deleting its C-terminal amino acid residues. , 2000, Biochemical and biophysical research communications.

[22]  Z. Xia,et al.  Crystal structures of the complexes of trichosanthin with four substrate analogs and catalytic mechanism of RNA N‐glycosidase , 2000, Proteins.

[23]  Ma Hui,et al.  Trichosanthin induced calcium-dependent generation of reactive oxygen species in human choriocarcinoma cells. , 2000 .

[24]  Y. Pommier,et al.  Solution Structure of Anti-HIV-1 and Anti-Tumor Protein MAP30 Structural Insights into Its Multiple Functions , 1999, Cell.

[25]  J. Eck,et al.  Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis. , 1999, Biochemical and biophysical research communications.

[26]  L. Yan,et al.  Role of Arg163 in the N-glycosidase activity of neo-trichosanthin. , 1999, Protein engineering.

[27]  L. Yan,et al.  Role of TYR70 in the N-glycosidase activity of neo-trichosanthin. , 1999, Toxicon : official journal of the International Society on Toxinology.

[28]  Wei Hu,et al.  Anti-HIV Agent Trichosanthin Enhances the Capabilities of Chemokines to Stimulate Chemotaxis and G Protein Activation, and This Is Mediated through Interaction of Trichosanthin and Chemokine Receptors , 1999, The Journal of experimental medicine.

[29]  P. Shaw,et al.  Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation. , 1999, Life sciences.

[30]  P. Shaw,et al.  Lowering of trichosanthin immunogenicity by site-specific coupling to dextran. , 1999, Biochemical pharmacology.

[31]  P. Shaw,et al.  Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity. , 1999, Life sciences.

[32]  S. Moestrup,et al.  Megalin-mediated endocytosis in renal proximal tubule. , 1998, Renal failure.

[33]  S. Tam,et al.  Position 120-123, a potential active site of trichosanthin. , 1998, Life sciences.

[34]  P. Shaw,et al.  The antigenic sites of trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties. , 1997, Life sciences.

[35]  P. Shaw,et al.  Structure/function relationship study of Tyr14 and Arg22 in trichosanthin, a ribosome-inactivating protein. , 1997, European journal of biochemistry.

[36]  T. Meyer,et al.  Clinical and pathological course of renal disease in non-insulin-dependent diabetes mellitus: the Pima Indian experience. , 1997, Seminars in nephrology.

[37]  Y. Ke,et al.  Structure-function relationship of trichosanthin. , 1997, Life sciences.

[38]  Qi-chen Huang,et al.  Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. , 1995, The Biochemical journal.

[39]  Y. Tsutsumi,et al.  Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency. , 1995, British Journal of Cancer.

[40]  P. Shaw,et al.  Mouse embryonic development and tumor cell growth under the influence of recombinant trichosanthin (a ribosome inactivating protein) and its muteins. , 1995, Teratogenesis, carcinogenesis, and mutagenesis.

[41]  Z. Fu,et al.  Structure of trichosanthin at 1.88 Å resolution , 1994, Proteins.

[42]  H. Yeung,et al.  Structure/function relationship study of Gln156, Glu160 and Glu189 in the active site of trichosanthin. , 1994, European journal of biochemistry.

[43]  J. Kahn,et al.  Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex , 1994, Antimicrobial Agents and Chemotherapy.

[44]  H. Yeung,et al.  Minireview: trichosanthin--a protein with multiple pharmacological properties. , 1994, Life sciences.

[45]  S. Wu,et al.  Refined structure of trichosanthin at 1.73 A resolution. , 1994, Science in China. Series B, Chemistry, life sciences & earth sciences.

[46]  D I Stuart,et al.  The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. , 1994, Structure.

[47]  J. S. Zhang,et al.  The mechanism of action of trichosanthin on eukaryotic ribosomes--RNA N-glycosidase activity of the cytotoxin. , 1992, Nucleic acids research.

[48]  L. O’Brien,et al.  Trichosanthin treatment of HIV‐induced immune dysregulation , 1992, European journal of clinical investigation.

[49]  H. Yeung,et al.  Increasing the plasma half-life of trichosanthin by coupling to dextran. , 1991, Biochemical pharmacology.

[50]  P. Andreasen,et al.  Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. , 1990, Cell regulation.

[51]  S. Lee-Huang,et al.  MAP 30: a new inhibitor of HIV‐1 infection and replication , 1990, FEBS letters.

[52]  M. McGrath,et al.  GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Yeung,et al.  Selective killing of choriocarcinoma cells in vitro by trichosanthin, a plant protein purified from root tubers of the Chinese medicinal herb Trichosanthes kirilowii. , 1986, Toxicon : official journal of the International Society on Toxinology.

[54]  Jin Yc.  [Intra-amniotic injection of crystal trichosanthin for induction of labour in second trimester pregnancy]. , 1985 .

[55]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.